X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (1063) 1063
humans (1047) 1047
pregnancy (1023) 1023
adult (722) 722
abortifacient agents, nonsteroidal - administration & dosage (617) 617
abortifacient agents, nonsteroidal - adverse effects (599) 599
obstetrics & gynecology (589) 589
misoprostol - administration & dosage (443) 443
misoprostol (430) 430
misoprostol - adverse effects (427) 427
index medicus (405) 405
abortion, induced - methods (356) 356
abortion (293) 293
treatment outcome (270) 270
administration, intravaginal (232) 232
abortifacient agents, nonsteroidal - therapeutic use (226) 226
mifepristone (225) 225
pregnancy trimester, first (219) 219
adolescent (197) 197
pregnancy trimester, second (190) 190
obstetrics and gynecology (186) 186
methotrexate (185) 185
pregnant women (177) 177
abortion, induced (173) 173
mifepristone - administration & dosage (166) 166
abortion, induced - adverse effects (157) 157
young adult (152) 152
prospective studies (147) 147
mifepristone - adverse effects (146) 146
medical abortion (131) 131
vaginal misoprostol (129) 129
methotrexate - administration & dosage (128) 128
abortifacient agents, steroidal - administration & dosage (127) 127
retrospective studies (127) 127
gestational age (123) 123
ectopic pregnancy (119) 119
reproductive biology (116) 116
administration, oral (115) 115
time factors (115) 115
misoprostol - therapeutic use (112) 112
methotrexate - therapeutic use (109) 109
methotrexate - adverse effects (103) 103
abortifacient agents, steroidal - adverse effects (101) 101
pregnancy, ectopic - drug therapy (100) 100
termination (99) 99
alprostadil - analogs & derivatives (92) 92
middle aged (89) 89
cesarean section - adverse effects (86) 86
abortifacient agents, nonsteroidal (82) 82
management (82) 82
women (81) 81
drug therapy, combination (79) 79
patient satisfaction (79) 79
dose-response relationship, drug (78) 78
alprostadil - adverse effects (71) 71
medicine, general & internal (70) 70
induction (69) 69
trial (68) 68
drug administration schedule (67) 67
administration, sublingual (60) 60
pregnancy, ectopic - therapy (59) 59
ultrasonography (58) 58
diagnosis (57) 57
dinoprostone - analogs & derivatives (55) 55
pregnancy, ectopic - diagnostic imaging (55) 55
risk factors (54) 54
care and treatment (53) 53
double-blind method (52) 52
abortifacient agents, nonsteroidal - pharmacology (51) 51
abridged index medicus (51) 51
follow-up studies (51) 51
pregnancy, ectopic (49) 49
alprostadil - administration & dosage (48) 48
miscarriage (48) 48
oral misoprostol (47) 47
gemeprost (46) 46
efficacy (45) 45
internal medicine (45) 45
pregnancy termination (45) 45
early-pregnancy (44) 44
gynecology (44) 44
surgery (43) 43
health aspects (42) 42
intravaginal misoprostol (42) 42
termination of pregnancy (42) 42
analysis (41) 41
dosage and administration (41) 41
gestation (40) 40
cervix uteri - drug effects (39) 39
chorionic gonadotropin - blood (39) 39
cicatrix - complications (39) 39
pregnancy, ectopic - etiology (39) 39
acceptability (38) 38
expectant management (38) 38
pregnancy, ectopic - surgery (38) 38
cesarean section (37) 37
male (37) 37
ultrasonography, prenatal (37) 37
injections, intramuscular (36) 36
pregnancy outcome (36) 36
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (981) 981
French (34) 34
German (27) 27
Chinese (14) 14
Spanish (10) 10
Dutch (9) 9
Danish (5) 5
Norwegian (4) 4
Portuguese (4) 4
Bulgarian (3) 3
Czech (3) 3
Russian (2) 2
Icelandic (1) 1
Italian (1) 1
Japanese (1) 1
Polish (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 23, pp. 2161 - 2170
Journal Article
Fertility and Sterility, ISSN 0015-0282, 2012, Volume 97, Issue 3, pp. 612 - 615
Objective To determine the efficacy of pre-emptive administration of the nonsteroidal anti-inflammatory drug (NSAID) ibuprofen vs. a placebo on pain relief... 
Internal Medicine | Obstetrics and Gynecology | Pain | misoprostol | ibuprofen | analgesics | medical abortion | mifepristone | placebo | pre-emptive | ACCEPTABILITY | PREGNANCY | OBSTETRICS & GYNECOLOGY | WOMEN | REPRODUCTIVE BIOLOGY | TERMINATION | ANALGESIA | Prospective Studies | Humans | Middle Aged | Misoprostol - administration & dosage | Abortifacient Agents, Nonsteroidal - adverse effects | Young Adult | Abortion, Induced - adverse effects | Time Factors | Abortifacient Agents, Nonsteroidal - administration & dosage | Pain - etiology | Placebos | Adult | Female | Surveys and Questionnaires | Odds Ratio | Mifepristone - administration & dosage | Abortifacient Agents, Steroidal - administration & dosage | Double-Blind Method | Drug Administration Schedule | Pain - prevention & control | Administration, Oral | Hospitals, University | Abortifacient Agents, Steroidal - adverse effects | Ibuprofen - administration & dosage | Logistic Models | Treatment Outcome | Chi-Square Distribution | Pregnancy | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Mifepristone - adverse effects | Adolescent | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Misoprostol - adverse effects | Ibuprofen - adverse effects | Israel | Pain Measurement | Pain - diagnosis | Analgesia | Care and treatment | Abortion | Misoprostol | Ibuprofen
Journal Article
Human reproduction (Oxford, England), ISSN 0268-1161, 2013, Volume 28, Issue 1, pp. 60 - 67
Journal Article
Journal Article